EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudiePragmatische StudieOpen Access · CC BY 4.0

Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes

Glucose Lowering through Weight management (GLoW): randomisierte kontrollierte Studie zur klinischen und Kosteneffektivität eines Diabetes-Schulungs- und Verhaltensprogramms zur Gewichtskontrolle versus Diabetes-Schulung bei Erwachsenen mit kürzlich diagnostiziertem Typ-2-Diabetes

Julia Mueller, Penny Breeze, Francesco Fusco, Stephen J Sharp, Katharine Pidd, Alan Brennan, Andrew J Hill, Stephen Morris, Carly A Hughes, Sarah E Bates, Daniel Pollard, Jenny Woolston und 10 weitere

Diabetologia · 2025-05 · 68 (5) · 969-980

DOI: 10.1007/s00125-024-06355-6 ↗

Auf einen Blick

Bei Erwachsenen mit kürzlich diagnostiziertem Typ-2-Diabetes senkte das Programm HbA1c bis 12 Monate nicht, führte aber zu Gewichtsverlust und war kosteneffektiv.

Fragestellung

Ist ein per Fernzugriff durchgeführtes, individuell angepasstes Diabetes-Schulungs- und Gewichtsmanagementprogramm wirksamer und kosteneffektiver als Standard-Diabetesedukation bei Typ-2-Diabetes?

Methode

Pragmatische randomisierte Parallelgruppenstudie in 159 hausärztlichen Praxen in England; Erwachsene mit Übergewicht/Adipositas und Typ-2-Diabetes ≤3 Jahre; Vergleich DEW vs. DE; Follow-up 0, 6 und 12 Monate.

Ergebnisse

577 Teilnehmende wurden randomisiert, 398 schlossen 12 Monate ab. Kein Effekt auf HbA1c nach 12 Monaten: Differenz −0,84 mmol/mol (95 %-KI −2,99 bis 1,31; p=0,44). Gewicht sank nach 6 und 12 Monaten; Remission häufiger unter DEW. DEW war kosteneffektiv.

Schlussfolgerung der Autor:innen

Ein kommerzielles Verhaltensprogramm zur Gewichtskontrolle mit Fernberatung verbesserte HbA1c bis 12 Monate nicht, könnte aber Gewichtsverlust fördern und kosteneffektiv sein.

Kernaussagen

  • Kein HbA1c-Effekt nach 12 Monaten: −0,84 mmol/mol
  • Gewicht geringer nach 6 und 12 Monaten unter DEW
  • Diabetesremission und Kosteneffektivität waren günstiger unter DEW

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Diabetologia, online erschienen am 23.01.2025. Verfasst von Julia Mueller und 21 weiteren Autor:innen. Beteiligte Einrichtung: MRC Epidemiology Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK. Julia.Mueller@mrc-epid.cam.ac.uk. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Weight Reduction Programs, Patient Education as Topic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research, NIHR Cambridge Biomedical Research Centre, Medical Research Council.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/hypothesis UK standard care for type 2 diabetes is structured diabetes education, with no effects on HbA 1c , small, short-term effects on weight and low uptake. We evaluated whether remotely delivered tailored diabetes education combined with commercial behavioural weight management is cost-effective compared with current standard care in helping people with type 2 diabetes to lower their blood glucose, lose weight, achieve remission and improve cardiovascular risk factors.

Methods

We conducted a pragmatic, randomised, parallel two-group trial. Participants were adults (≥18 years) with overweight or obesity (BMI≥25 kg/m 2 ) and recently diagnosed with type 2 diabetes (≤3 years), recruited from 159 primary care practices in England. We randomised participants to a tailored diabetes education and behavioural weight management programme (DEW; delivered by Weight Watchers) or to current standard care diabetes education (DE; Diabetes Education and Self Management for Ongoing and Newly Diagnosed [DESMOND] programme), using a computer-generated randomisation sequence in a 1:1 allocation stratified by gender and diabetes duration, unknown to those collecting and analysing the data. Participants could not be blinded due to the nature of the interventions. Participants completed assessments at 0, 6 and 12 months. The primary outcome was 12 month change from baseline in HbA 1c . We also assessed bodyweight, blood pressure, cholesterol (total, HDL, LDL), glucose-lowering medication, behavioural measures (physical activity, food intake), psychosocial measures (eating behaviour, diabetes-related quality of life, wellbeing) and within-trial and modelled lifetime cost effectiveness.

Results

We randomised 577 participants (DEW: 289, DE: 288); 398 (69%) completed 12 month follow-up. We found no evidence for an intervention effect on change in HbA 1c from baseline to 12 months (difference: −0.84 [95% CI −2.99, 1.31] mmol/mol, p =0.44) or 6 months (−1.83 [−4.05, 0.40] mmol/mol). We found an intervention effect on weight at 6 (−1.77 [−2.86, −0.67] kg) and 12 months (−1.38 [−2.56, −0.19] kg). Participants in DEW had a higher likelihood of achieving diabetes remission than participants in DE (6 months: RR 2.10 [95% CI 1.03, 4.47]; 12 months: RR 2.53 [1.30, 5.16]). DEW was cost-effective compared with DE in within-trial and lifetime analyses, in the latter generating an incremental cost effectiveness ratio of £2290 per quality-adjusted life year gained. Conclusions/interpretation A commercial behavioural weight management programme combined with remote dietary counselling after diagnosis of type 2 diabetes did not improve HbA 1c up to 12 months post intervention in this trial. The intervention could help people achieve weight loss and be cost-effective compared with current standard National Health Service care.

Trial registration

ISRCTN 18399564 Funding National Institute for Health and Care Research (NIHR; RP-PG-0216-20010), Medical Research Council (MC_UU_00006/6), NIHR Cambridge Biomedical Research Centre (NIHR203312). Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Weight Reduction ProgramsPatient Education as TopicHumansMaleFemaleMiddle AgedCost-Benefit AnalysisAdultBlood GlucoseAgedGlycated HemoglobinWeight LossObesityBehavior TherapyCost-Effectiveness Analysis

Stichwörter der Autor:innen

Behavioural weight managementDiabetes mellitus, type 2ObesityOverweightRandomised controlled trialWeight lossWeight reduction programmes

Substanzen

Blood GlucoseGlycated Hemoglobin

Autor:innen und Institutionen

  • MRC Epidemiology Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK. Julia.Mueller@mrc-epid.cam.ac.uk.
  • Sheffield Centre for Health and Related Research (SCHARR), School of Medicine and Population Health, University of Sheffield, Sheffield, UK.
  • Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Broadstreet Health Economics & Outcomes Research, Vancouver, BC, Canada.
  • MRC Epidemiology Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
  • School of Medicine, University of Leeds, Leeds, UK.

Förderung

  • National Institute for Health and Care Research
  • NIHR Cambridge Biomedical Research Centre
  • Medical Research Council

Zitieren

APA

Mueller, J., Breeze, P., Fusco, F., Sharp, S. J., Pidd, K., Brennan, A., Hill, A. J., Morris, S., Hughes, C. A., Bates, S. E., Pollard, D., Woolston, J., Lachassseigne, E., Stubbings, M., Whittle, F., Jones, R. A., Boothby, C. E., Duschinsky, R., Bostock, J., …, & Ahern, A. L. (2025). Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes. Diabetologia, 68(5), 969-980. https://doi.org/10.1007/s00125-024-06355-6

Vancouver

Mueller J, Breeze P, Fusco F, Sharp SJ, Pidd K, Brennan A, et al. Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes. Diabetologia. 2025;68(5):969-980. doi:10.1007/s00125-024-06355-6

BibTeX
@article{Mueller2025,
  author = {Mueller, Julia and Breeze, Penny and Fusco, Francesco and Sharp, Stephen J and Pidd, Katharine and Brennan, Alan and Hill, Andrew J and Morris, Stephen and Hughes, Carly A and Bates, Sarah E and Pollard, Daniel and Woolston, Jenny and Lachassseigne, Emma and Stubbings, Marie and Whittle, Fiona and Jones, Rebecca A and Boothby, Clare E and Duschinsky, Robbie and Bostock, Jennifer and Islam, Nazrul and Griffin, Simon J and Ahern, Amy L},
  title = {Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes},
  journal = {Diabetologia},
  year = {2025},
  volume = {68},
  number = {5},
  pages = {969--980},
  doi = {10.1007/s00125-024-06355-6}
}
Kostenlos starten →